Ethinylestradiol/drospirenone: similar VTE risk to other combined OCs

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2004年 / 1028卷 / 1期
关键词：
Cohort Study; Oral Contraceptive; Venous Thromboembolism; Current Problem; Monitoring Study;
D O I：
10.2165/00128415-200410280-00001
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2 / 2
相关论文
共 24 条
  • [21] Combined OCs may increase breast cancer risk in women aged < 35 years
    Reactions Weekly, 2000, 802 (1) : 5 - 5
  • [22] TXA combined with whole blood transfusion in trauma patients does not increase the risk of VTE but shock index does
    Myers, John C.
    Murphy, Samantha
    Limon, David
    Gerhardus, Christian
    Barry, Lauran
    Brigmon, Erika
    Eastridge, Brian
    Braverman, Maxwell A.
    Reveles, Kelly
    Nicholson, Susannah
    Jenkins, Donald
    AMERICAN JOURNAL OF SURGERY, 2024, 238
  • [23] Effects of a combined oral contraceptive containing 20 mcg of ethinylestradiol and 3mg of drospirenone on the blood pressure, renin-angiotensin-aldosterone system, insulin resistance, and androgenic profile of healthy young women
    Galvao Giribela, Cassiana Rosa
    Consolim-Colombo, Fernanda Marciano
    Nisenbaum, Marcelo Gil
    de Moraes, Tercio Lemos
    Galvao Giribela, Aricia Helena
    Baracat, Edmund Chada
    de Melo, Nilson Roberto
    GYNECOLOGICAL ENDOCRINOLOGY, 2015, 31 (11) : 912 - 915
  • [24] Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users
    Sidney, Stephen
    Cheetham, T. Craig
    Connell, Frederick A.
    Ouellet-Hellstrom, Rita
    Graham, David J.
    Davis, Daniel
    Sorel, Michael
    Quesenberry, Charles P., Jr.
    Cooper, William O.
    CONTRACEPTION, 2013, 87 (01) : 93 - 100
123